Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Down 65.1% in June

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 142,100 shares, a decrease of 65.1% from the June 15th total of 407,416 shares. Based on an average daily volume of 2,234,493 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Advanced Medical Isotope Price Performance

Shares of OTCMKTS:RDGL opened at $0.08 on Monday. The company has a market cap of $40.46 million, a P/E ratio of -8.19 and a beta of -0.75. Advanced Medical Isotope has a 52 week low of $0.04 and a 52 week high of $0.15. The business has a fifty day simple moving average of $0.07 and a 200-day simple moving average of $0.07.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.